Immutep Limited announced encouraging interim survival data from the EFTISARC-NEO Phase II trial combining eftilagimod alfa (efti) with KEYTRUDA and radiotherapy for resectable soft tissue sarcoma. With a median follow-up of 19.1 months, 12-month disease-free survival was 81.1%, local recurrence-free survival 94.1%, and distant metastasis-free survival 86.2% among 38 patients. These results suggest the combination therapy may improve long-term outcomes and support further registrational trials. Additional analyses will be presented at the CTOS 2026 Annual Meeting in November.
The Immutep interim survival data from the EFTISARC-NEO trial provides context for health sector performance. For readers following health stocks, here is Pluang's market snapshot as of Nov 11, 2026 04:52 WIB: Of 150 priced health-sector US stocks, 49 rose and 100 fell. ACAD rose 10.06% to USD 18.16 with a typical hold time of 77 days, contrasting with WGS which dropped 16.08% to USD 55.15 and INO down 13.91% at USD 1.30, where WGS saw 100% buy order activity while INO had 72% buy orders.
Cannabis Strategic Ventures has finalized its change of control with Scopien Technologies, an AI platform company, which now holds voting control through preferred stock. The company has appointed new leadership, including CEO Zameer Mulla, and plans...
Star Bulk Carriers Corp. has published its 2025 Environmental, Social and Governance (ESG) Report, its eighth annual report detailing the company's sustainability strategy, performance, and future objectives. The report, guided by the ESG Committee, ...
TELA Bio reported $19 million revenue in Q3 2026, down 8% year-over-year but with an 18% increase in international sales. The company reduced its operating loss by 21% sequentially and improved adjusted EBITDA loss by 55%, driven by a strategic cost ...
Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...
OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...
